Jeremy M. Levin, CEO, 10% Owner at Ovid Therapeutics Inc. (OVID), bought 8,488 shares at $5.84 ($50K) on 2020-08-28, disclosed to the SEC on 2020-09-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| OVID | BUY | 2019-02-26 | $150K | — | Filing → |
| OVID | BUY | 2017-08-28 | $219K | — | Filing → |